BeOne Medicines (ONC) Cash from Operations (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.76% |
| Dec 31, 2025 | 3.68% |
| Sep 30, 2025 | 52.71% |
| Jun 30, 2025 | 497.97% |
| Mar 31, 2025 | -41.35% |
| Dec 31, 2024 | -60.10% |
| Sep 30, 2024 | 297.06% |
| Jun 30, 2024 | 69.02% |
| Mar 31, 2024 | -39.22% |
| Dec 31, 2023 | -183.61% |
| Sep 30, 2023 | 73.41% |
| Jun 30, 2023 | 47.87% |
| Mar 31, 2023 | -77.18% |
| Dec 31, 2022 | 43.37% |
| Sep 30, 2022 | -47.89% |
| Jun 30, 2022 | -60.62% |
| Mar 31, 2022 | -286.14% |
| Dec 31, 2021 | 125.64% |
| Sep 30, 2021 | -17.95% |
| Jun 30, 2021 | -435.96% |
| Mar 31, 2021 | 137.64% |
| Dec 31, 2020 | 4.02% |
| Sep 30, 2020 | -31.68% |
| Jun 30, 2020 | 23.10% |
| Mar 31, 2020 | -27.98% |
| Dec 31, 2019 | -0.82% |
| Sep 30, 2019 | -474.85% |
| Jun 30, 2019 | 73.19% |
| Mar 31, 2019 | 11.30% |
| Dec 31, 2018 | -46.68% |
| Sep 30, 2018 | -12.85% |
| Jun 30, 2018 | -12.09% |
| Mar 31, 2018 | -211.47% |
| Dec 31, 2017 | 1,320.44% |
| Sep 30, 2017 | 112.72% |
| Jun 30, 2017 | -45.29% |
| Mar 31, 2017 | -36.61% |
| Dec 31, 2016 | -7.68% |
| Sep 30, 2016 | -26.07% |
| Jun 30, 2016 | 2.95% |
| Mar 31, 2016 | -18.37% |
| Dec 31, 2015 | -69.67% |
| Sep 30, 2015 | -4.09% |
| Jun 30, 2015 | -155.75% |